Showing 1 of 1 PublicationsThe FDA And Regulation Of Cost-Effectiveness ClaimsNeumann P, Ƶinner D, Paltiel A. The FDA And Regulation Of Cost-Effectiveness Claims. Health Affairs 1996, 15: 54-71. PMID: 8854508, DOI: 10.1377/hlthaff.15.3.54.Peer-Reviewed Original ResearchCitationsMeSH KeywordsCost-Benefit AnalysisDrug CostsDrug IndustryEconomics, PharmaceuticalHumansModels, EconomicPrivate SectorStreptokinaseTissue Plasminogen ActivatorUnited StatesUnited States Food and Drug AdministrationDownload Full List
The FDA And Regulation Of Cost-Effectiveness ClaimsNeumann P, Ƶinner D, Paltiel A. The FDA And Regulation Of Cost-Effectiveness Claims. Health Affairs 1996, 15: 54-71. PMID: 8854508, DOI: 10.1377/hlthaff.15.3.54.Peer-Reviewed Original ResearchCitationsMeSH KeywordsCost-Benefit AnalysisDrug CostsDrug IndustryEconomics, PharmaceuticalHumansModels, EconomicPrivate SectorStreptokinaseTissue Plasminogen ActivatorUnited StatesUnited States Food and Drug Administration